Placebo and Active Controlled Study of Rivoglitazone in Type 2 Diabetes
Public ClinicalTrials.gov record NCT00143520. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Double-dummy, Placebo-controlled 26-week Dose-response Study of Rivoglitazone HCl (CS-011) With Active Comparator (Pioglitazone HCl) in Subjects With Type 2 Diabetes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a 6-month study to evaluate the effects of monotherapy with rivoglitazone, an insulin sensitizer, on glycemic control in newly identified type 2 diabetics or diabetics not adequately treated with other antidiabetic agents. The study tests rivoglitazone and uses a placebo and active treatment group for comparison.
Study identification
- NCT ID
- NCT00143520
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 441 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2004 (Type not available)
- Primary completion
- Dec 2005 (Actual)
- Completion
- Dec 2005 (Actual)
- Last update posted
- May 10, 2021
2004 – 2005
United States locations
- U.S. sites
- 74
- U.S. states
- 26
- U.S. cities
- 74
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | — | — |
| Not listed | Columbiana | Alabama | — | — |
| Not listed | Huntsville | Alabama | — | — |
| Not listed | Muscle Shoals | Alabama | — | — |
| Not listed | Hot Springs | Arkansas | — | — |
| Not listed | Jonesboro | Arkansas | — | — |
| Not listed | Little Rock | Arkansas | — | — |
| Not listed | Searcy | Arkansas | — | — |
| Not listed | Sherwood | Arkansas | — | — |
| Not listed | Los Angeles | California | — | — |
| Not listed | Moreno Valley | California | — | — |
| Not listed | Sacramento | California | — | — |
| Not listed | San Diego | California | — | — |
| Not listed | San Mateo | California | — | — |
| Not listed | Santa Monica | California | — | — |
| Not listed | Torrance | California | — | — |
| Not listed | Vista | California | — | — |
| Not listed | West Hills | California | — | — |
| Not listed | Newark | Delaware | — | — |
| Not listed | Clearwater | Florida | — | — |
| Not listed | Cocoa Beach | Florida | — | — |
| Not listed | Jupiter | Florida | — | — |
| Not listed | Largo | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | New Port Richey | Florida | — | — |
| Not listed | Palm Harbor | Florida | — | — |
| Not listed | Pembroke Pines | Florida | — | — |
| Not listed | Tampa | Florida | — | — |
| Not listed | West Palm Beach | Florida | — | — |
| Not listed | Warner Robins | Georgia | — | — |
| Not listed | Chicago | Illinois | — | — |
| Not listed | Gurnee | Illinois | — | — |
| Not listed | Evansville | Indiana | — | — |
| Not listed | Lexington | Kentucky | — | — |
| Not listed | New Orleans | Louisiana | — | — |
| Not listed | Detroit | Michigan | — | — |
| Not listed | Livonia | Michigan | — | — |
| Not listed | Kansas City | Missouri | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Bozeman | Montana | — | — |
| Not listed | Butte | Montana | — | — |
| Not listed | Great Falls | Montana | — | — |
| Not listed | Voorhees Township | New Jersey | — | — |
| Not listed | Rochester | New York | — | — |
| Not listed | Charlotte | North Carolina | — | — |
| Not listed | Statesville | North Carolina | — | — |
| Not listed | Winston-Salem | North Carolina | — | — |
| Not listed | Cincinnati | Ohio | — | — |
| Not listed | Columbus | Ohio | — | — |
| Not listed | Marion | Ohio | — | — |
| Not listed | Clinton | Oklahoma | — | — |
| Not listed | Oklahoma City | Oklahoma | — | — |
| Not listed | Tulsa | Oklahoma | — | — |
| Not listed | Medford | Oregon | — | — |
| Not listed | Philadelphia | Pennsylvania | — | — |
| Not listed | Pittsburgh | Pennsylvania | — | — |
| Not listed | Charleston | South Carolina | — | — |
| Not listed | Simpsonville | South Carolina | — | — |
| Not listed | Bristol | Tennessee | — | — |
| Not listed | Carrollton | Texas | — | — |
| Not listed | Conroe | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | Midland | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Spring | Texas | — | — |
| Not listed | Sugar Land | Texas | — | — |
| Not listed | Norfolk | Virginia | — | — |
| Not listed | Richmond | Virginia | — | — |
| Not listed | Virginia Beach | Virginia | — | — |
| Not listed | Lakewood | Washington | — | — |
| Not listed | Olympia | Washington | — | — |
| Not listed | Renton | Washington | — | — |
| Not listed | Spokane | Washington | — | — |
| Not listed | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00143520, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 10, 2021 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00143520 live on ClinicalTrials.gov.